SCHEDULE: AQR Capital Management Reports Stake in Outset Medical

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported beneficial ownership of 5.39% of Outset Medical, Inc.'s common stock as of June 30, 2026.

Summary

• AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed a Schedule 13G, indicating their beneficial ownership of Outset Medical, Inc. common stock.
• As of June 30, 2026, the reporting entities collectively beneficially owned 998,961 shares, representing 5.39% of the class of securities.
• AQR Capital Management, LLC holds shared power to vote and dispose of 966,795 shares, and shared power to dispose of an additional 32,166 shares, totaling 998,961 shares.
• AQR Capital Management Holdings, LLC, as the parent entity, also has shared voting and disposition power over the same 998,961 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new operational or financial information.

Positives

• The filing indicates a significant institutional investor, AQR Capital Management, holds a notable stake in Outset Medical, which can be seen as a sign of confidence.
• The reporting entities confirm the shares are held in the ordinary course of business, suggesting a standard investment approach rather than a hostile takeover attempt.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Outset Medical, Inc., offering no insight into the company's operational health.
• The disclosure is a routine filing for beneficial ownership changes and does not inherently signal positive or negative developments for the company's stock performance.

Risks

• The concentration of ownership by a single entity, AQR Capital Management, could potentially influence market dynamics if they decide to significantly alter their position.
• While not explicitly stated as a risk in this filing, any significant shift in holdings by large institutional investors can create volatility.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Outset Medical, Inc.'s future performance.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating or reporting significant stakes in public companies. This filing indicates AQR Capital Management's investment activity in the medical technology sector, specifically within Outset Medical.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which could influence market perception and trading activity.
• Management: The certification by AQR Capital Management implies no intent to influence or control the issuer's management.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• AQR Capital Management will continue to hold or potentially adjust its position in Outset Medical, Inc. common stock.
• Outset Medical, Inc. may experience market reactions based on institutional investor activity, though this filing itself does not dictate future performance.

Key Dates

Keywords

beneficial ownership, Schedule 13G, institutional investor, common stock, AQR Capital Management, Outset Medical